🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/12/1992 | 0,1193 USD |
| 31/08/1992 | 0,1193 USD |
| 02/06/1992 | 0,1097 USD |
| 02/03/1992 | 0,1097 USD |
| 02/12/1991 | 0,1002 USD |
| 30/08/1991 | 0,1002 USD |
| 03/06/1991 | 0,0891 USD |
| 04/03/1991 | 0,0891 USD |
| 03/12/1990 | 0,0891 USD |
| 28/08/1990 | 0,0891 USD |
| 29/05/1990 | 0,0716 USD |
| 05/03/1990 | 0,0716 USD |
| 04/12/1989 | 0,0716 USD |
| 29/08/1989 | 0,0716 USD |
| 30/05/1989 | 0,0652 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 19/03/1976 | 1,85 | 1,88 | 1,85 | 1,87 | +1,62% | 1,62% | 1.290.298 |
| 18/03/1976 | 1,86 | 1,87 | 1,84 | 1,84 | -0,72% | 1,78% | 2.237.270 |
| 17/03/1976 | 1,85 | 1,88 | 1,85 | 1,86 | +0,54% | 1,62% | 2.305.181 |
| 16/03/1976 | 1,80 | 1,85 | 1,80 | 1,85 | +3,53% | 2,77% | 2.097.677 |
| 15/03/1976 | 1,80 | 1,80 | 1,78 | 1,78 | -1,10% | 1,47% | 2.810.736 |
| 12/03/1976 | 1,83 | 1,85 | 1,80 | 1,80 | -1,45% | 2,90% | 2.803.190 |
| 11/03/1976 | 1,84 | 1,85 | 1,83 | 1,83 | -0,72% | 1,08% | 1.595.894 |
| 10/03/1976 | 1,84 | 1,86 | 1,84 | 1,84 | +0,00% | 1,44% | 4.210.445 |
| 09/03/1976 | 1,84 | 1,88 | 1,83 | 1,84 | +0,36% | 2,53% | 3.191.789 |
| 08/03/1976 | 1,80 | 1,85 | 1,80 | 1,84 | +2,40% | 2,76% | 1.637.395 |
| 05/03/1976 | 1,78 | 1,80 | 1,78 | 1,79 | +0,56% | 0,93% | 2.414.592 |
| 04/03/1976 | 1,79 | 1,81 | 1,77 | 1,78 | -0,37% | 1,85% | 1.969.402 |
| 03/03/1976 | 1,79 | 1,80 | 1,78 | 1,79 | +0,00% | 1,48% | 2.161.814 |
| 02/03/1976 | 1,79 | 1,81 | 1,78 | 1,79 | +0,00% | 1,67% | 3.195.562 |
| 01/03/1976 | 1,79 | 1,82 | 1,78 | 1,79 | +0,00% | 2,03% | 2.595.686 |
| 27/02/1976 | 1,79 | 1,82 | 1,77 | 1,79 | -0,18% | 2,40% | 2.225.952 |
| 26/02/1976 | 1,81 | 1,83 | 1,79 | 1,79 | -0,92% | 2,20% | 3.599.251 |
| 25/02/1976 | 1,83 | 1,83 | 1,80 | 1,81 | -0,91% | 1,63% | 3.425.702 |
| 24/02/1976 | 1,83 | 1,85 | 1,81 | 1,83 | -0,18% | 1,81% | 2.320.272 |
| 23/02/1976 | 1,85 | 1,86 | 1,81 | 1,83 | -1,25% | 2,51% | 3.418.157 |
| 20/02/1976 | 1,86 | 1,86 | 1,84 | 1,85 | -0,18% | 1,07% | 3.719.981 |
| 19/02/1976 | 1,85 | 1,88 | 1,85 | 1,86 | +0,36% | 1,61% | 1.595.894 |
| 18/02/1976 | 1,86 | 1,87 | 1,84 | 1,85 | -0,71% | 1,42% | 2.889.965 |
| 17/02/1976 | 1,88 | 1,88 | 1,86 | 1,86 | -0,88% | 1,06% | 1.867.536 |
| 13/02/1976 | 1,90 | 1,91 | 1,88 | 1,88 | -1,22% | 1,91% | 1.467.619 |
| 12/02/1976 | 1,92 | 1,93 | 1,89 | 1,90 | -0,69% | 1,73% | 1.158.250 |
| 11/02/1976 | 1,92 | 1,93 | 1,89 | 1,92 | -0,17% | 1,73% | 2.607.005 |
| 10/02/1976 | 1,91 | 1,93 | 1,90 | 1,92 | +0,69% | 1,39% | 3.346.474 |
| 09/02/1976 | 1,91 | 1,93 | 1,88 | 1,91 | -0,17% | 2,60% | 1.671.350 |
| 06/02/1976 | 1,92 | 1,92 | 1,87 | 1,91 | -0,69% | 2,42% | 2.018.448 |